Enteral @entity20553 supplement promotes intestinal adaptation in XXXX .

@entity20553 @entity1160 @entity535 @entity72951 @entity35 @entity493
Although parental administration of @entity1160 promotes intestinal adaptation, it is controversial whether enteral @entity1160 is effective after small bowel resection. To further evaluate the benefits of enteral supplementation, peptide and @entity535 peptide transporter function must be considered. We evaluated the effect of enteral @entity20553 based on the alteration of peptide and @entity535 transporter expressions after massive small intestinal resection. @entity35 underwent 80% proximal intestinal resection. Expression of the glutaminase (GA), @entity535 transporter B0 and peptide transporter @entity72951 mRNA in the residual intestinal cells was initially examined by Northern blot analysis. @entity35 with a small bowel received a bolus supplement of @entity1160 (2.0 g/kg/day) + @entity493 (1.22 g/kg/day) mixture, @entity20553 (2.972/kg/day) or saline for 3 days from one day before operation. On the 3rd postoperative day (POD) and the 7th POD, residual intestinal tissue was removed, and mucosal parameters were measured. The GA activity and GA mRNA significantly increased on the 1st POD. Although the levels of B0 mRNA gradually decreased, the @entity72951 mRNA increased after surgery, and reached 150% of the initial level on the 5th POD. In the @entity35 administered @entity20553 , mucosal wet weight and protein content similarly increased with increasing villus height on the 7th POD. Enteral supplementation with @entity20553 but not @entity1160 + @entity493 mixture promotes intestinal adaptation as evidenced by increased peptide transport after intestinal resection.
